Co-Diagnostics, Inc. Announces Completion of the Acquisition of all Assets and Intellectual Property Related to At-Home/Point-of-Care Platform

SALT LAKE CITY, Dec. 31, 2021 /PRNewswire/ -- Co-Diagnostics, Inc.  , a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests,... | December 31, 2021

Related Keywords

Idaho ,United States ,Utah ,Kirk Ririe ,Dwight Egan ,Carl Wittwer ,Conceptions Inc ,Diagnostics Inc Nasdaq ,Idaho Molecular Inc ,Diagnostics Inc ,Company Scientific Advisory Board ,Idaho Molecular ,Advanced Conceptions ,Scientific Advisory ,Looking Statements ,Co Diagnostics ,Nc Stock Exchange ,News ,Information ,Press Release ,Salt ,Lake ,021 ,Olecular ,Iagnostics ,Company ,Ith ,Atented ,Platform ,Or ,The ,Development ,F ,Iagnostic Codx Us1897631057 ,